Anesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan, Italy.
Br J Anaesth. 2013 Dec;111(6):886-96. doi: 10.1093/bja/aet231. Epub 2013 Jul 12.
Many studies have compared desflurane, isoflurane, sevoflurane, total i.v. anaesthesia (TIVA), or all in cardiac surgery to assess their effects on patient survival.
We performed standard pairwise and Bayesian network meta-analyses; the latter allows indirect assessments if any of the anaesthetic agents were not compared in head-to-head trials. Pertinent studies were identified using BioMedCentral, MEDLINE/PubMed, Embase, and the Cochrane Library (last updated in June 2012).
We identified 38 randomized trials with survival data published between 1991 and 2012, with most studies (63%) done in coronary artery bypass grafting (CABG) patients with standard cardiopulmonary bypass. Standard meta-analysis showed that the use of a volatile agent was associated with a reduction in mortality when compared with TIVA at the longest follow-up available [25/1994 (1.3%) in the volatile group vs 43/1648 (2.6%) in the TIVA arm, odds ratio (OR)=0.51, 95% confidence interval (CI) 0.33-0.81, P-value for effect=0.004, number needed to treat 74, I(2)=0%] with results confirmed in trials with low risk of bias, in large trials, and when including only CABG studies. Bayesian network meta-analysis showed that sevoflurane (OR=0.31, 95% credible interval 0.14-0.64) and desflurane (OR=0.43, 95% credible interval 0.21-0.82) were individually associated with a reduction in mortality when compared with TIVA.
Anaesthesia with volatile agents appears to reduce mortality after cardiac surgery when compared with TIVA, especially when sevoflurane or desflurane is used. A large, multicentre trial is warranted to confirm that long-term survival is significantly affected by the choice of anaesthetic.
许多研究比较了地氟烷、异氟烷、七氟烷、全静脉麻醉(TIVA)或心脏手术中的所有这些麻醉药物,以评估它们对患者生存率的影响。
我们进行了标准的成对和贝叶斯网络荟萃分析;如果任何一种麻醉药物没有在头对头试验中进行比较,则贝叶斯网络荟萃分析允许进行间接评估。使用生物医学中心、MEDLINE/PubMed、Embase 和 Cochrane 图书馆(最后更新于 2012 年 6 月)检索相关研究。
我们确定了 38 项有生存数据的随机试验,这些试验发表于 1991 年至 2012 年期间,其中大多数研究(63%)是在标准体外循环下进行的冠状动脉旁路移植术(CABG)患者中进行的。标准荟萃分析显示,与最长随访期可用的 TIVA 相比,使用挥发性药物与死亡率降低相关[挥发性组 25/1994(1.3%),TIVA 组 43/1648(2.6%),比值比(OR)=0.51,95%置信区间(CI)0.33-0.81,P 值=0.004,需要治疗的人数为 74,I(2)=0%],并且在低偏倚风险的试验、大型试验和仅包括 CABG 研究中得到了证实。贝叶斯网络荟萃分析显示,与 TIVA 相比,七氟烷(OR=0.31,95%可信区间 0.14-0.64)和地氟烷(OR=0.43,95%可信区间 0.21-0.82)单独使用时与死亡率降低相关。
与 TIVA 相比,心脏手术后使用挥发性麻醉药物似乎可降低死亡率,尤其是使用七氟烷或地氟烷时。需要进行一项大型的多中心试验来证实长期生存率是否会受到麻醉选择的显著影响。